SAMIR PATEL: Open Payments
NPI 1740732544 · NEWCASTLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $137 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 1 | $122 |
| Supernus Pharmaceuticals, Inc. | 1 | $120 |
| GlaxoSmithKline, LLC. | 1 | $117 |
Products named: YCANTH, Qelbree, PENMENVY.
Industry payments across OK — which companies pay providers there.
